EVERSANA, a pioneer of next-generation commercial services to the global life sciences industry, announced the acquisition of Accelera Canada and its partner companies Patient Access Solutions, Podium Strategic Partners Inc. and Advocacy Solutions.
EVERSANA, a pioneer of next generation commercial services to the global life sciences industry, on May 6 announced key appointments across Europe to further strengthen the company’s worldwide market access and pricing solutions leadership position.
EVERSANA announces broad-scale strategic partnerships with industry leaders in claims, EMR, formulary and provider-institutional data to optimize real-time commercial services EVERSANA and Symphony Health announce multi-year relationship for EMR claims and data infrastructure EVERSANA and Compile partner to integrate physician affiliation data to drive market access commercial services, with additional formulary data partnership in final […]
EVERSANA, a leading provider of commercial services to the life science industry, announced the acquisition of HVH Precision Analytics and its predictive analytics platform.
EVERSANA, a leading independent provider of global commercial services to the life sciences industry, announced the appointment of Brigham Hyde, Ph.D. to President, Data & Analytics (D&A).
In essence, we all want those boots on the ground to drive commercial value. Yet, not every high-priced pair of shoes delivers the desired ROI. Physician access time or practice location, and position of the brand in its life cycle, often make the cost of deploying a traditional field rep undesirable. Yet, many brands benefit from a personal visit to the office.
PDI to Focus on Growing Molecular Diagnostics Business; Plans to Change Name to Interpace Diagnostics Group PDI to receive $25.5 to $32.5 million up front cash payment and a contingent earnout payment Combination Would Create A Global Leader in Healthcare Commercial Services PARSIPPANY, N.J. & YARDLEY, Pa., Nov. 2, 2015 /PRNewswire/ — PDI, Inc. (Nasdaq: […]